Eleanor Manners

The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status

L. Kenner, Ji Luo, O. Merkel, 2019, Nature Communications.

Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma

S. Turner, J. Kaggie, R. Trigg, 2024, Nature communications.